Global Newcastle Disease Vaccine Market Growth 2026-2032
The global Newcastle Disease Vaccine market size is predicted to grow from US$ 338 million in 2025 to US$ 426 million in 2032; it is expected to grow at a CAGR of 3.4% from 2026 to 2032.
Newcastle Disease Vaccine is a critical biological product used to prevent Newcastle disease, a highly contagious viral infection affecting poultry such as chickens and ducks. The vaccine works by stimulating the immune system to produce specific antibodies and cellular immune responses against the Newcastle disease virus (NDV), thereby reducing infection rates, mortality, and viral transmission. Depending on production technology and immunological characteristics, it can be categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each suited for different farming systems and immunization programs. With the ongoing industrialization and intensification of modern poultry farming, Newcastle disease vaccines have become an essential tool for ensuring biosecurity and controlling major infectious diseases, holding a significant position in the global animal vaccine market.In 2025, global Newcastle Disease Vaccine production reached approximately 138.29 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry meat and egg consumption and the expansion of large-scale farming operations, demand for Newcastle disease vaccines remains strong. Governments worldwide are strengthening animal disease prevention systems and incorporating vaccination into mandatory or recommended programs, significantly increasing market penetration. Meanwhile, large-scale farming enterprises are placing greater emphasis on biosecurity, transforming vaccines from a cost factor into a critical risk management tool. According to corporate reports and industry practices, vaccine technologies are evolving toward higher efficacy, improved safety, and multivalent formulations, enhancing application scope and product value.Despite strong growth, the industry faces several challenges. Vaccine production requires stringent biosafety and quality control standards, leading to complex processes and higher operational costs. Variations in viral strains across regions demand continuous technological upgrades to maintain efficacy. In addition, price competition and product homogenization in certain markets put pressure on profit margins. Limitations in cold chain logistics and uneven vaccination practices at the grassroots level may also affect overall disease control outcomes.Downstream demand is shifting from fragmented farming to large-scale and standardized operations, driving more systematic and regulated vaccine usage. Large poultry producers are establishing comprehensive immunization programs, demanding higher consistency and reliability from vaccine products. At the same time, expansion of poultry farming in emerging markets is creating new demand opportunities. Increasing awareness of food safety and animal welfare is also driving demand for vaccines with higher safety profiles and fewer side effects, promoting industry premiumization.Upstream components mainly include viral seed strains, culture media, embryonated eggs, and adjuvants. High-quality seed strains and stable biological cultivation systems are fundamental to vaccine development and production, directly impacting efficacy and safety. With advances in biotechnology, upstream processes are becoming more standardized and scalable, although key materials still involve significant technical barriers. Supply chain stability and quality consistency are increasingly critical competitive factors in the industry.
LP Information, Inc. (LPI) ' newest research report, the ?Newcastle Disease Vaccine Industry Forecast? looks at past sales and reviews total world Newcastle Disease Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Newcastle Disease Vaccine sales for 2026 through 2032. With Newcastle Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newcastle Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Newcastle Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Newcastle Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Newcastle Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newcastle Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newcastle Disease Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Newcastle Disease Vaccine is a critical biological product used to prevent Newcastle disease, a highly contagious viral infection affecting poultry such as chickens and ducks. The vaccine works by stimulating the immune system to produce specific antibodies and cellular immune responses against the Newcastle disease virus (NDV), thereby reducing infection rates, mortality, and viral transmission. Depending on production technology and immunological characteristics, it can be categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines, each suited for different farming systems and immunization programs. With the ongoing industrialization and intensification of modern poultry farming, Newcastle disease vaccines have become an essential tool for ensuring biosecurity and controlling major infectious diseases, holding a significant position in the global animal vaccine market.In 2025, global Newcastle Disease Vaccine production reached approximately 138.29 billion doses and price is about 2.5 USD/ K Dose. The average gross profit margin of this product is 15%.
Driven by the continuous growth in global poultry meat and egg consumption and the expansion of large-scale farming operations, demand for Newcastle disease vaccines remains strong. Governments worldwide are strengthening animal disease prevention systems and incorporating vaccination into mandatory or recommended programs, significantly increasing market penetration. Meanwhile, large-scale farming enterprises are placing greater emphasis on biosecurity, transforming vaccines from a cost factor into a critical risk management tool. According to corporate reports and industry practices, vaccine technologies are evolving toward higher efficacy, improved safety, and multivalent formulations, enhancing application scope and product value.Despite strong growth, the industry faces several challenges. Vaccine production requires stringent biosafety and quality control standards, leading to complex processes and higher operational costs. Variations in viral strains across regions demand continuous technological upgrades to maintain efficacy. In addition, price competition and product homogenization in certain markets put pressure on profit margins. Limitations in cold chain logistics and uneven vaccination practices at the grassroots level may also affect overall disease control outcomes.Downstream demand is shifting from fragmented farming to large-scale and standardized operations, driving more systematic and regulated vaccine usage. Large poultry producers are establishing comprehensive immunization programs, demanding higher consistency and reliability from vaccine products. At the same time, expansion of poultry farming in emerging markets is creating new demand opportunities. Increasing awareness of food safety and animal welfare is also driving demand for vaccines with higher safety profiles and fewer side effects, promoting industry premiumization.Upstream components mainly include viral seed strains, culture media, embryonated eggs, and adjuvants. High-quality seed strains and stable biological cultivation systems are fundamental to vaccine development and production, directly impacting efficacy and safety. With advances in biotechnology, upstream processes are becoming more standardized and scalable, although key materials still involve significant technical barriers. Supply chain stability and quality consistency are increasingly critical competitive factors in the industry.
LP Information, Inc. (LPI) ' newest research report, the ?Newcastle Disease Vaccine Industry Forecast? looks at past sales and reviews total world Newcastle Disease Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Newcastle Disease Vaccine sales for 2026 through 2032. With Newcastle Disease Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newcastle Disease Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Newcastle Disease Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Newcastle Disease Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Newcastle Disease Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newcastle Disease Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newcastle Disease Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Newcastle Disease Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Live Vaccines
- Killed Vaccines
- Spray Method
- Drinking Water
- Injection Method
- Large Farms
- Small Farms
- Government Use
- Chicken
- Duck & Goose
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- CEVA
- CAHIC
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- Elanco
- FATRO
- CAVAC
- Vaksindo
- Virbac
- Hester Biosciences
- What is the 10-year outlook for the global Newcastle Disease Vaccine market?
- What factors are driving Newcastle Disease Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doNewcastle Disease Vaccine market opportunities vary by end market size?
- How does Newcastle Disease Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newcastle Disease Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Newcastle Disease Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Newcastle Disease Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Newcastle Disease Vaccine Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.2.3 Newcastle Disease Vaccine Sales by Type
2.2.3.1 Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Newcastle Disease Vaccine Sale Price by Type (2021-2026)
2.3 Newcastle Disease Vaccine Segment by Administration
2.3.1 Spray Method
2.3.2 Drinking Water
2.3.3 Injection Method
2.3.4 Newcastle Disease Vaccine Sales by Administration
2.3.4.1 Global Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
2.3.4.2 Global Newcastle Disease Vaccine Revenue and Market Share by Administration (2021-2026)
2.3.4.3 Global Newcastle Disease Vaccine Sale Price by Administration (2021-2026)
2.4 Newcastle Disease Vaccine Segment by End User
2.4.1 Large Farms
2.4.2 Small Farms
2.4.3 Government Use
2.4.4 Newcastle Disease Vaccine Sales by End User
2.4.4.1 Global Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
2.4.4.2 Global Newcastle Disease Vaccine Revenue and Market Share by End User (2021-2026)
2.4.4.3 Global Newcastle Disease Vaccine Sale Price by End User (2021-2026)
2.5 Newcastle Disease Vaccine Segment by Application
2.5.1 Chicken
2.5.2 Duck & Goose
2.5.3 Other
2.5.4 Newcastle Disease Vaccine Sales by Application
2.5.4.1 Global Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
2.5.4.2 Global Newcastle Disease Vaccine Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Newcastle Disease Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Newcastle Disease Vaccine Breakdown Data by Company
3.1.1 Global Newcastle Disease Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Newcastle Disease Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Newcastle Disease Vaccine Revenue by Company (2021-2026)
3.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Newcastle Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Newcastle Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Newcastle Disease Vaccine Product Location Distribution
3.4.2 Players Newcastle Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Newcastle Disease Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Newcastle Disease Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Newcastle Disease Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Newcastle Disease Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Newcastle Disease Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Newcastle Disease Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Newcastle Disease Vaccine Sales Growth
4.4 APAC Newcastle Disease Vaccine Sales Growth
4.5 Europe Newcastle Disease Vaccine Sales Growth
4.6 Middle East & Africa Newcastle Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Newcastle Disease Vaccine Sales by Country
5.1.1 Americas Newcastle Disease Vaccine Sales by Country (2021-2026)
5.1.2 Americas Newcastle Disease Vaccine Revenue by Country (2021-2026)
5.2 Americas Newcastle Disease Vaccine Sales by Type (2021-2026)
5.3 Americas Newcastle Disease Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newcastle Disease Vaccine Sales by Region
6.1.1 APAC Newcastle Disease Vaccine Sales by Region (2021-2026)
6.1.2 APAC Newcastle Disease Vaccine Revenue by Region (2021-2026)
6.2 APAC Newcastle Disease Vaccine Sales by Type (2021-2026)
6.3 APAC Newcastle Disease Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Newcastle Disease Vaccine by Country
7.1.1 Europe Newcastle Disease Vaccine Sales by Country (2021-2026)
7.1.2 Europe Newcastle Disease Vaccine Revenue by Country (2021-2026)
7.2 Europe Newcastle Disease Vaccine Sales by Type (2021-2026)
7.3 Europe Newcastle Disease Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newcastle Disease Vaccine by Country
8.1.1 Middle East & Africa Newcastle Disease Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Newcastle Disease Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Newcastle Disease Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine
10.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
10.4 Industry Chain Structure of Newcastle Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Newcastle Disease Vaccine Distributors
11.3 Newcastle Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Newcastle Disease Vaccine Market Size Forecast by Region
12.1.1 Global Newcastle Disease Vaccine Forecast by Region (2027-2032)
12.1.2 Global Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Newcastle Disease Vaccine Forecast by Type (2027-2032)
12.7 Global Newcastle Disease Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Newcastle Disease Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 CEVA
13.2.1 CEVA Company Information
13.2.2 CEVA Newcastle Disease Vaccine Product Portfolios and Specifications
13.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CEVA Main Business Overview
13.2.5 CEVA Latest Developments
13.3 CAHIC
13.3.1 CAHIC Company Information
13.3.2 CAHIC Newcastle Disease Vaccine Product Portfolios and Specifications
13.3.3 CAHIC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CAHIC Main Business Overview
13.3.5 CAHIC Latest Developments
13.4 Ringpu Biology
13.4.1 Ringpu Biology Company Information
13.4.2 Ringpu Biology Newcastle Disease Vaccine Product Portfolios and Specifications
13.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ringpu Biology Main Business Overview
13.4.5 Ringpu Biology Latest Developments
13.5 Yebio
13.5.1 Yebio Company Information
13.5.2 Yebio Newcastle Disease Vaccine Product Portfolios and Specifications
13.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yebio Main Business Overview
13.5.5 Yebio Latest Developments
13.6 Harbin Veterinary Research Institute
13.6.1 Harbin Veterinary Research Institute Company Information
13.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolios and Specifications
13.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Veterinary Research Institute Main Business Overview
13.6.5 Harbin Veterinary Research Institute Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Newcastle Disease Vaccine Product Portfolios and Specifications
13.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Newcastle Disease Vaccine Product Portfolios and Specifications
13.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 Zoetis
13.9.1 Zoetis Company Information
13.9.2 Zoetis Newcastle Disease Vaccine Product Portfolios and Specifications
13.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Zoetis Main Business Overview
13.9.5 Zoetis Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Newcastle Disease Vaccine Product Portfolios and Specifications
13.10.3 Elanco Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 FATRO
13.11.1 FATRO Company Information
13.11.2 FATRO Newcastle Disease Vaccine Product Portfolios and Specifications
13.11.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 FATRO Main Business Overview
13.11.5 FATRO Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Newcastle Disease Vaccine Product Portfolios and Specifications
13.12.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Vaksindo
13.13.1 Vaksindo Company Information
13.13.2 Vaksindo Newcastle Disease Vaccine Product Portfolios and Specifications
13.13.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Vaksindo Main Business Overview
13.13.5 Vaksindo Latest Developments
13.14 Virbac
13.14.1 Virbac Company Information
13.14.2 Virbac Newcastle Disease Vaccine Product Portfolios and Specifications
13.14.3 Virbac Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Virbac Main Business Overview
13.14.5 Virbac Latest Developments
13.15 Hester Biosciences
13.15.1 Hester Biosciences Company Information
13.15.2 Hester Biosciences Newcastle Disease Vaccine Product Portfolios and Specifications
13.15.3 Hester Biosciences Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Hester Biosciences Main Business Overview
13.15.5 Hester Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Newcastle Disease Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Newcastle Disease Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Newcastle Disease Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Newcastle Disease Vaccine Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.2.3 Newcastle Disease Vaccine Sales by Type
2.2.3.1 Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Newcastle Disease Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Newcastle Disease Vaccine Sale Price by Type (2021-2026)
2.3 Newcastle Disease Vaccine Segment by Administration
2.3.1 Spray Method
2.3.2 Drinking Water
2.3.3 Injection Method
2.3.4 Newcastle Disease Vaccine Sales by Administration
2.3.4.1 Global Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
2.3.4.2 Global Newcastle Disease Vaccine Revenue and Market Share by Administration (2021-2026)
2.3.4.3 Global Newcastle Disease Vaccine Sale Price by Administration (2021-2026)
2.4 Newcastle Disease Vaccine Segment by End User
2.4.1 Large Farms
2.4.2 Small Farms
2.4.3 Government Use
2.4.4 Newcastle Disease Vaccine Sales by End User
2.4.4.1 Global Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
2.4.4.2 Global Newcastle Disease Vaccine Revenue and Market Share by End User (2021-2026)
2.4.4.3 Global Newcastle Disease Vaccine Sale Price by End User (2021-2026)
2.5 Newcastle Disease Vaccine Segment by Application
2.5.1 Chicken
2.5.2 Duck & Goose
2.5.3 Other
2.5.4 Newcastle Disease Vaccine Sales by Application
2.5.4.1 Global Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
2.5.4.2 Global Newcastle Disease Vaccine Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Newcastle Disease Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Newcastle Disease Vaccine Breakdown Data by Company
3.1.1 Global Newcastle Disease Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Newcastle Disease Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Newcastle Disease Vaccine Revenue by Company (2021-2026)
3.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Newcastle Disease Vaccine Sale Price by Company
3.4 Key Manufacturers Newcastle Disease Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Newcastle Disease Vaccine Product Location Distribution
3.4.2 Players Newcastle Disease Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Newcastle Disease Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Newcastle Disease Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Newcastle Disease Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Newcastle Disease Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Newcastle Disease Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Newcastle Disease Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Newcastle Disease Vaccine Sales Growth
4.4 APAC Newcastle Disease Vaccine Sales Growth
4.5 Europe Newcastle Disease Vaccine Sales Growth
4.6 Middle East & Africa Newcastle Disease Vaccine Sales Growth
5 AMERICAS
5.1 Americas Newcastle Disease Vaccine Sales by Country
5.1.1 Americas Newcastle Disease Vaccine Sales by Country (2021-2026)
5.1.2 Americas Newcastle Disease Vaccine Revenue by Country (2021-2026)
5.2 Americas Newcastle Disease Vaccine Sales by Type (2021-2026)
5.3 Americas Newcastle Disease Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Newcastle Disease Vaccine Sales by Region
6.1.1 APAC Newcastle Disease Vaccine Sales by Region (2021-2026)
6.1.2 APAC Newcastle Disease Vaccine Revenue by Region (2021-2026)
6.2 APAC Newcastle Disease Vaccine Sales by Type (2021-2026)
6.3 APAC Newcastle Disease Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Newcastle Disease Vaccine by Country
7.1.1 Europe Newcastle Disease Vaccine Sales by Country (2021-2026)
7.1.2 Europe Newcastle Disease Vaccine Revenue by Country (2021-2026)
7.2 Europe Newcastle Disease Vaccine Sales by Type (2021-2026)
7.3 Europe Newcastle Disease Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Newcastle Disease Vaccine by Country
8.1.1 Middle East & Africa Newcastle Disease Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Newcastle Disease Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Newcastle Disease Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine
10.3 Manufacturing Process Analysis of Newcastle Disease Vaccine
10.4 Industry Chain Structure of Newcastle Disease Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Newcastle Disease Vaccine Distributors
11.3 Newcastle Disease Vaccine Customer
12 WORLD FORECAST REVIEW FOR NEWCASTLE DISEASE VACCINE BY GEOGRAPHIC REGION
12.1 Global Newcastle Disease Vaccine Market Size Forecast by Region
12.1.1 Global Newcastle Disease Vaccine Forecast by Region (2027-2032)
12.1.2 Global Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Newcastle Disease Vaccine Forecast by Type (2027-2032)
12.7 Global Newcastle Disease Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Newcastle Disease Vaccine Product Portfolios and Specifications
13.1.3 Boehringer Ingelheim Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 CEVA
13.2.1 CEVA Company Information
13.2.2 CEVA Newcastle Disease Vaccine Product Portfolios and Specifications
13.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CEVA Main Business Overview
13.2.5 CEVA Latest Developments
13.3 CAHIC
13.3.1 CAHIC Company Information
13.3.2 CAHIC Newcastle Disease Vaccine Product Portfolios and Specifications
13.3.3 CAHIC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CAHIC Main Business Overview
13.3.5 CAHIC Latest Developments
13.4 Ringpu Biology
13.4.1 Ringpu Biology Company Information
13.4.2 Ringpu Biology Newcastle Disease Vaccine Product Portfolios and Specifications
13.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Ringpu Biology Main Business Overview
13.4.5 Ringpu Biology Latest Developments
13.5 Yebio
13.5.1 Yebio Company Information
13.5.2 Yebio Newcastle Disease Vaccine Product Portfolios and Specifications
13.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yebio Main Business Overview
13.5.5 Yebio Latest Developments
13.6 Harbin Veterinary Research Institute
13.6.1 Harbin Veterinary Research Institute Company Information
13.6.2 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolios and Specifications
13.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Harbin Veterinary Research Institute Main Business Overview
13.6.5 Harbin Veterinary Research Institute Latest Developments
13.7 Merck Animal Health
13.7.1 Merck Animal Health Company Information
13.7.2 Merck Animal Health Newcastle Disease Vaccine Product Portfolios and Specifications
13.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Animal Health Main Business Overview
13.7.5 Merck Animal Health Latest Developments
13.8 DHN
13.8.1 DHN Company Information
13.8.2 DHN Newcastle Disease Vaccine Product Portfolios and Specifications
13.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DHN Main Business Overview
13.8.5 DHN Latest Developments
13.9 Zoetis
13.9.1 Zoetis Company Information
13.9.2 Zoetis Newcastle Disease Vaccine Product Portfolios and Specifications
13.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Zoetis Main Business Overview
13.9.5 Zoetis Latest Developments
13.10 Elanco
13.10.1 Elanco Company Information
13.10.2 Elanco Newcastle Disease Vaccine Product Portfolios and Specifications
13.10.3 Elanco Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Elanco Main Business Overview
13.10.5 Elanco Latest Developments
13.11 FATRO
13.11.1 FATRO Company Information
13.11.2 FATRO Newcastle Disease Vaccine Product Portfolios and Specifications
13.11.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 FATRO Main Business Overview
13.11.5 FATRO Latest Developments
13.12 CAVAC
13.12.1 CAVAC Company Information
13.12.2 CAVAC Newcastle Disease Vaccine Product Portfolios and Specifications
13.12.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 CAVAC Main Business Overview
13.12.5 CAVAC Latest Developments
13.13 Vaksindo
13.13.1 Vaksindo Company Information
13.13.2 Vaksindo Newcastle Disease Vaccine Product Portfolios and Specifications
13.13.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Vaksindo Main Business Overview
13.13.5 Vaksindo Latest Developments
13.14 Virbac
13.14.1 Virbac Company Information
13.14.2 Virbac Newcastle Disease Vaccine Product Portfolios and Specifications
13.14.3 Virbac Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Virbac Main Business Overview
13.14.5 Virbac Latest Developments
13.15 Hester Biosciences
13.15.1 Hester Biosciences Company Information
13.15.2 Hester Biosciences Newcastle Disease Vaccine Product Portfolios and Specifications
13.15.3 Hester Biosciences Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Hester Biosciences Main Business Overview
13.15.5 Hester Biosciences Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Newcastle Disease Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Newcastle Disease Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 6. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Newcastle Disease Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Newcastle Disease Vaccine Sale Price by Type (2021-2026) & (USD/K Doses)
Table 10. Major Players of Spray Method
Table 11. Major Players of Drinking Water
Table 12. Major Players of Injection Method
Table 13. Global Newcastle Disease Vaccine Sales by Administration (2021-2026) & (M Doses)
Table 14. Global Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
Table 15. Global Newcastle Disease Vaccine Revenue by Administration (2021-2026) & ($ million)
Table 16. Global Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Table 17. Global Newcastle Disease Vaccine Sale Price by Administration (2021-2026) & (USD/K Doses)
Table 18. Major Players of Large Farms
Table 19. Major Players of Small Farms
Table 20. Major Players of Government Use
Table 21. Global Newcastle Disease Vaccine Sales by End User (2021-2026) & (M Doses)
Table 22. Global Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
Table 23. Global Newcastle Disease Vaccine Revenue by End User (2021-2026) & ($ million)
Table 24. Global Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Table 25. Global Newcastle Disease Vaccine Sale Price by End User (2021-2026) & (USD/K Doses)
Table 26. Global Newcastle Disease Vaccine Sale by Application (2021-2026) & (M Doses)
Table 27. Global Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
Table 28. Global Newcastle Disease Vaccine Revenue by Application (2021-2026) & ($ million)
Table 29. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026)
Table 30. Global Newcastle Disease Vaccine Sale Price by Application (2021-2026) & (USD/K Doses)
Table 31. Global Newcastle Disease Vaccine Sales by Company (2021-2026) & (M Doses)
Table 32. Global Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
Table 33. Global Newcastle Disease Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
Table 35. Global Newcastle Disease Vaccine Sale Price by Company (2021-2026) & (USD/K Doses)
Table 36. Key Manufacturers Newcastle Disease Vaccine Producing Area Distribution and Sales Area
Table 37. Players Newcastle Disease Vaccine Products Offered
Table 38. Newcastle Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Newcastle Disease Vaccine Sales by Geographic Region (2021-2026) & (M Doses)
Table 42. Global Newcastle Disease Vaccine Sales Market Share Geographic Region (2021-2026)
Table 43. Global Newcastle Disease Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Newcastle Disease Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Newcastle Disease Vaccine Sales by Country/Region (2021-2026) & (M Doses)
Table 46. Global Newcastle Disease Vaccine Sales Market Share by Country/Region (2021-2026)
Table 47. Global Newcastle Disease Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Newcastle Disease Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 50. Americas Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Table 51. Americas Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 53. Americas Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 54. APAC Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses)
Table 55. APAC Newcastle Disease Vaccine Sales Market Share by Region (2021-2026)
Table 56. APAC Newcastle Disease Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 58. APAC Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 59. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 60. Europe Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 62. Europe Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 63. Middle East & Africa Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 64. Middle East & Africa Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 66. Middle East & Africa Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 67. Key Market Drivers & Growth Opportunities of Newcastle Disease Vaccine
Table 68. Key Market Challenges & Risks of Newcastle Disease Vaccine
Table 69. Key Industry Trends of Newcastle Disease Vaccine
Table 70. Newcastle Disease Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Newcastle Disease Vaccine Distributors List
Table 73. Newcastle Disease Vaccine Customer List
Table 74. Global Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (M Doses)
Table 75. Global Newcastle Disease Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses)
Table 77. Americas Newcastle Disease Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (M Doses)
Table 79. APAC Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses)
Table 81. Europe Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses)
Table 83. Middle East & Africa Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Newcastle Disease Vaccine Sales Forecast by Type (2027-2032) & (M Doses)
Table 85. Global Newcastle Disease Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Newcastle Disease Vaccine Sales Forecast by Application (2027-2032) & (M Doses)
Table 87. Global Newcastle Disease Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Boehringer Ingelheim Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Newcastle Disease Vaccine Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. CEVA Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CEVA Newcastle Disease Vaccine Product Portfolios and Specifications
Table 95. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 96. CEVA Main Business
Table 97. CEVA Latest Developments
Table 98. CAHIC Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CAHIC Newcastle Disease Vaccine Product Portfolios and Specifications
Table 100. CAHIC Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 101. CAHIC Main Business
Table 102. CAHIC Latest Developments
Table 103. Ringpu Biology Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology Newcastle Disease Vaccine Product Portfolios and Specifications
Table 105. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Yebio Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Newcastle Disease Vaccine Product Portfolios and Specifications
Table 110. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. Harbin Veterinary Research Institute Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolios and Specifications
Table 115. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 116. Harbin Veterinary Research Institute Main Business
Table 117. Harbin Veterinary Research Institute Latest Developments
Table 118. Merck Animal Health Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck Animal Health Newcastle Disease Vaccine Product Portfolios and Specifications
Table 120. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 121. Merck Animal Health Main Business
Table 122. Merck Animal Health Latest Developments
Table 123. DHN Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Newcastle Disease Vaccine Product Portfolios and Specifications
Table 125. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
Table 128. Zoetis Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Zoetis Newcastle Disease Vaccine Product Portfolios and Specifications
Table 130. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 131. Zoetis Main Business
Table 132. Zoetis Latest Developments
Table 133. Elanco Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Elanco Newcastle Disease Vaccine Product Portfolios and Specifications
Table 135. Elanco Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 136. Elanco Main Business
Table 137. Elanco Latest Developments
Table 138. FATRO Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. FATRO Newcastle Disease Vaccine Product Portfolios and Specifications
Table 140. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 141. FATRO Main Business
Table 142. FATRO Latest Developments
Table 143. CAVAC Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. CAVAC Newcastle Disease Vaccine Product Portfolios and Specifications
Table 145. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 146. CAVAC Main Business
Table 147. CAVAC Latest Developments
Table 148. Vaksindo Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Vaksindo Newcastle Disease Vaccine Product Portfolios and Specifications
Table 150. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 151. Vaksindo Main Business
Table 152. Vaksindo Latest Developments
Table 153. Virbac Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Virbac Newcastle Disease Vaccine Product Portfolios and Specifications
Table 155. Virbac Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 156. Virbac Main Business
Table 157. Virbac Latest Developments
Table 158. Hester Biosciences Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Hester Biosciences Newcastle Disease Vaccine Product Portfolios and Specifications
Table 160. Hester Biosciences Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 161. Hester Biosciences Main Business
Table 162. Hester Biosciences Latest Developments
Table 1. Newcastle Disease Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Newcastle Disease Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 6. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Newcastle Disease Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Newcastle Disease Vaccine Sale Price by Type (2021-2026) & (USD/K Doses)
Table 10. Major Players of Spray Method
Table 11. Major Players of Drinking Water
Table 12. Major Players of Injection Method
Table 13. Global Newcastle Disease Vaccine Sales by Administration (2021-2026) & (M Doses)
Table 14. Global Newcastle Disease Vaccine Sales Market Share by Administration (2021-2026)
Table 15. Global Newcastle Disease Vaccine Revenue by Administration (2021-2026) & ($ million)
Table 16. Global Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Table 17. Global Newcastle Disease Vaccine Sale Price by Administration (2021-2026) & (USD/K Doses)
Table 18. Major Players of Large Farms
Table 19. Major Players of Small Farms
Table 20. Major Players of Government Use
Table 21. Global Newcastle Disease Vaccine Sales by End User (2021-2026) & (M Doses)
Table 22. Global Newcastle Disease Vaccine Sales Market Share by End User (2021-2026)
Table 23. Global Newcastle Disease Vaccine Revenue by End User (2021-2026) & ($ million)
Table 24. Global Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Table 25. Global Newcastle Disease Vaccine Sale Price by End User (2021-2026) & (USD/K Doses)
Table 26. Global Newcastle Disease Vaccine Sale by Application (2021-2026) & (M Doses)
Table 27. Global Newcastle Disease Vaccine Sale Market Share by Application (2021-2026)
Table 28. Global Newcastle Disease Vaccine Revenue by Application (2021-2026) & ($ million)
Table 29. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026)
Table 30. Global Newcastle Disease Vaccine Sale Price by Application (2021-2026) & (USD/K Doses)
Table 31. Global Newcastle Disease Vaccine Sales by Company (2021-2026) & (M Doses)
Table 32. Global Newcastle Disease Vaccine Sales Market Share by Company (2021-2026)
Table 33. Global Newcastle Disease Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 34. Global Newcastle Disease Vaccine Revenue Market Share by Company (2021-2026)
Table 35. Global Newcastle Disease Vaccine Sale Price by Company (2021-2026) & (USD/K Doses)
Table 36. Key Manufacturers Newcastle Disease Vaccine Producing Area Distribution and Sales Area
Table 37. Players Newcastle Disease Vaccine Products Offered
Table 38. Newcastle Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global Newcastle Disease Vaccine Sales by Geographic Region (2021-2026) & (M Doses)
Table 42. Global Newcastle Disease Vaccine Sales Market Share Geographic Region (2021-2026)
Table 43. Global Newcastle Disease Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global Newcastle Disease Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global Newcastle Disease Vaccine Sales by Country/Region (2021-2026) & (M Doses)
Table 46. Global Newcastle Disease Vaccine Sales Market Share by Country/Region (2021-2026)
Table 47. Global Newcastle Disease Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global Newcastle Disease Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 50. Americas Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Table 51. Americas Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 53. Americas Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 54. APAC Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses)
Table 55. APAC Newcastle Disease Vaccine Sales Market Share by Region (2021-2026)
Table 56. APAC Newcastle Disease Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 58. APAC Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 59. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 60. Europe Newcastle Disease Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 62. Europe Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 63. Middle East & Africa Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses)
Table 64. Middle East & Africa Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses)
Table 66. Middle East & Africa Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses)
Table 67. Key Market Drivers & Growth Opportunities of Newcastle Disease Vaccine
Table 68. Key Market Challenges & Risks of Newcastle Disease Vaccine
Table 69. Key Industry Trends of Newcastle Disease Vaccine
Table 70. Newcastle Disease Vaccine Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Newcastle Disease Vaccine Distributors List
Table 73. Newcastle Disease Vaccine Customer List
Table 74. Global Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (M Doses)
Table 75. Global Newcastle Disease Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses)
Table 77. Americas Newcastle Disease Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC Newcastle Disease Vaccine Sales Forecast by Region (2027-2032) & (M Doses)
Table 79. APAC Newcastle Disease Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses)
Table 81. Europe Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa Newcastle Disease Vaccine Sales Forecast by Country (2027-2032) & (M Doses)
Table 83. Middle East & Africa Newcastle Disease Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global Newcastle Disease Vaccine Sales Forecast by Type (2027-2032) & (M Doses)
Table 85. Global Newcastle Disease Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global Newcastle Disease Vaccine Sales Forecast by Application (2027-2032) & (M Doses)
Table 87. Global Newcastle Disease Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. Boehringer Ingelheim Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Newcastle Disease Vaccine Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. CEVA Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. CEVA Newcastle Disease Vaccine Product Portfolios and Specifications
Table 95. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 96. CEVA Main Business
Table 97. CEVA Latest Developments
Table 98. CAHIC Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CAHIC Newcastle Disease Vaccine Product Portfolios and Specifications
Table 100. CAHIC Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 101. CAHIC Main Business
Table 102. CAHIC Latest Developments
Table 103. Ringpu Biology Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ringpu Biology Newcastle Disease Vaccine Product Portfolios and Specifications
Table 105. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 106. Ringpu Biology Main Business
Table 107. Ringpu Biology Latest Developments
Table 108. Yebio Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Yebio Newcastle Disease Vaccine Product Portfolios and Specifications
Table 110. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 111. Yebio Main Business
Table 112. Yebio Latest Developments
Table 113. Harbin Veterinary Research Institute Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolios and Specifications
Table 115. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 116. Harbin Veterinary Research Institute Main Business
Table 117. Harbin Veterinary Research Institute Latest Developments
Table 118. Merck Animal Health Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Merck Animal Health Newcastle Disease Vaccine Product Portfolios and Specifications
Table 120. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 121. Merck Animal Health Main Business
Table 122. Merck Animal Health Latest Developments
Table 123. DHN Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. DHN Newcastle Disease Vaccine Product Portfolios and Specifications
Table 125. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 126. DHN Main Business
Table 127. DHN Latest Developments
Table 128. Zoetis Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Zoetis Newcastle Disease Vaccine Product Portfolios and Specifications
Table 130. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 131. Zoetis Main Business
Table 132. Zoetis Latest Developments
Table 133. Elanco Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Elanco Newcastle Disease Vaccine Product Portfolios and Specifications
Table 135. Elanco Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 136. Elanco Main Business
Table 137. Elanco Latest Developments
Table 138. FATRO Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. FATRO Newcastle Disease Vaccine Product Portfolios and Specifications
Table 140. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 141. FATRO Main Business
Table 142. FATRO Latest Developments
Table 143. CAVAC Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. CAVAC Newcastle Disease Vaccine Product Portfolios and Specifications
Table 145. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 146. CAVAC Main Business
Table 147. CAVAC Latest Developments
Table 148. Vaksindo Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Vaksindo Newcastle Disease Vaccine Product Portfolios and Specifications
Table 150. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 151. Vaksindo Main Business
Table 152. Vaksindo Latest Developments
Table 153. Virbac Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Virbac Newcastle Disease Vaccine Product Portfolios and Specifications
Table 155. Virbac Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 156. Virbac Main Business
Table 157. Virbac Latest Developments
Table 158. Hester Biosciences Basic Information, Newcastle Disease Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Hester Biosciences Newcastle Disease Vaccine Product Portfolios and Specifications
Table 160. Hester Biosciences Newcastle Disease Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2021-2026)
Table 161. Hester Biosciences Main Business
Table 162. Hester Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Picture of Newcastle Disease Vaccine
Figure 2. Newcastle Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Newcastle Disease Vaccine Sales Growth Rate 2021-2032 (M Doses)
Figure 7. Global Newcastle Disease Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Newcastle Disease Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Newcastle Disease Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Newcastle Disease Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Killed Vaccines
Figure 13. Global Newcastle Disease Vaccine Sales Market Share by Type in 2026
Figure 14. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Spray Method
Figure 16. Product Picture of Drinking Water
Figure 17. Product Picture of Injection Method
Figure 18. Global Newcastle Disease Vaccine Sales Market Share by Administration in 2026
Figure 19. Global Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Figure 20. Product Picture of Large Farms
Figure 21. Product Picture of Small Farms
Figure 22. Product Picture of Government Use
Figure 23. Global Newcastle Disease Vaccine Sales Market Share by End User in 2026
Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Figure 25. Newcastle Disease Vaccine Consumed in Chicken
Figure 26. Global Newcastle Disease Vaccine Market: Chicken (2021-2026) & (M Doses)
Figure 27. Newcastle Disease Vaccine Consumed in Duck & Goose
Figure 28. Global Newcastle Disease Vaccine Market: Duck & Goose (2021-2026) & (M Doses)
Figure 29. Newcastle Disease Vaccine Consumed in Other
Figure 30. Global Newcastle Disease Vaccine Market: Other (2021-2026) & (M Doses)
Figure 31. Global Newcastle Disease Vaccine Sale Market Share by Application (2025)
Figure 32. Global Newcastle Disease Vaccine Revenue Market Share by Application in 2025
Figure 33. Newcastle Disease Vaccine Sales by Company in 2025 (M Doses)
Figure 34. Global Newcastle Disease Vaccine Sales Market Share by Company in 2025
Figure 35. Newcastle Disease Vaccine Revenue by Company in 2025 ($ millions)
Figure 36. Global Newcastle Disease Vaccine Revenue Market Share by Company in 2025
Figure 37. Global Newcastle Disease Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Newcastle Disease Vaccine Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 40. Americas Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 41. APAC Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 42. APAC Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 43. Europe Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 44. Europe Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 46. Middle East & Africa Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 47. Americas Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 48. Americas Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 49. Americas Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 50. Americas Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 51. United States Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Newcastle Disease Vaccine Sales Market Share by Region in 2025
Figure 56. APAC Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026)
Figure 57. APAC Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 58. APAC Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 59. China Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. India Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 67. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 68. Europe Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 69. Europe Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 70. Germany Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. France Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 78. Egypt Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine in 2026
Figure 84. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 85. Industry Chain Structure of Newcastle Disease Vaccine
Figure 86. Channels of Distribution
Figure 87. Global Newcastle Disease Vaccine Sales Market Forecast by Region (2027-2032)
Figure 88. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Newcastle Disease Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Newcastle Disease Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Newcastle Disease Vaccine
Figure 2. Newcastle Disease Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Newcastle Disease Vaccine Sales Growth Rate 2021-2032 (M Doses)
Figure 7. Global Newcastle Disease Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Newcastle Disease Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Newcastle Disease Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Newcastle Disease Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Live Vaccines
Figure 12. Product Picture of Killed Vaccines
Figure 13. Global Newcastle Disease Vaccine Sales Market Share by Type in 2026
Figure 14. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Spray Method
Figure 16. Product Picture of Drinking Water
Figure 17. Product Picture of Injection Method
Figure 18. Global Newcastle Disease Vaccine Sales Market Share by Administration in 2026
Figure 19. Global Newcastle Disease Vaccine Revenue Market Share by Administration (2021-2026)
Figure 20. Product Picture of Large Farms
Figure 21. Product Picture of Small Farms
Figure 22. Product Picture of Government Use
Figure 23. Global Newcastle Disease Vaccine Sales Market Share by End User in 2026
Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by End User (2021-2026)
Figure 25. Newcastle Disease Vaccine Consumed in Chicken
Figure 26. Global Newcastle Disease Vaccine Market: Chicken (2021-2026) & (M Doses)
Figure 27. Newcastle Disease Vaccine Consumed in Duck & Goose
Figure 28. Global Newcastle Disease Vaccine Market: Duck & Goose (2021-2026) & (M Doses)
Figure 29. Newcastle Disease Vaccine Consumed in Other
Figure 30. Global Newcastle Disease Vaccine Market: Other (2021-2026) & (M Doses)
Figure 31. Global Newcastle Disease Vaccine Sale Market Share by Application (2025)
Figure 32. Global Newcastle Disease Vaccine Revenue Market Share by Application in 2025
Figure 33. Newcastle Disease Vaccine Sales by Company in 2025 (M Doses)
Figure 34. Global Newcastle Disease Vaccine Sales Market Share by Company in 2025
Figure 35. Newcastle Disease Vaccine Revenue by Company in 2025 ($ millions)
Figure 36. Global Newcastle Disease Vaccine Revenue Market Share by Company in 2025
Figure 37. Global Newcastle Disease Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Newcastle Disease Vaccine Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 40. Americas Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 41. APAC Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 42. APAC Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 43. Europe Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 44. Europe Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Newcastle Disease Vaccine Sales 2021-2026 (M Doses)
Figure 46. Middle East & Africa Newcastle Disease Vaccine Revenue 2021-2026 ($ millions)
Figure 47. Americas Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 48. Americas Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 49. Americas Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 50. Americas Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 51. United States Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Newcastle Disease Vaccine Sales Market Share by Region in 2025
Figure 56. APAC Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026)
Figure 57. APAC Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 58. APAC Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 59. China Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. India Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Newcastle Disease Vaccine Sales Market Share by Country in 2025
Figure 67. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2021-2026)
Figure 68. Europe Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 69. Europe Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 70. Germany Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. France Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Application (2021-2026)
Figure 78. Egypt Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Newcastle Disease Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine in 2026
Figure 84. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 85. Industry Chain Structure of Newcastle Disease Vaccine
Figure 86. Channels of Distribution
Figure 87. Global Newcastle Disease Vaccine Sales Market Forecast by Region (2027-2032)
Figure 88. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Newcastle Disease Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Newcastle Disease Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Newcastle Disease Vaccine Revenue Market Share Forecast by Application (2027-2032)
